BiomX Corporporation
BiomX Corporation is a clinical-stage biotechnology company focused on developing innovative therapies targeting the microbiome to address unmet medical needs. Leveraging advanced microbiome modulation technologies, BiomX designs and engineers phage-based solutions aimed at treating chronic diseases, including those related to the gut and skin. The company’s pipeline includes candidates for conditions such as inflammatory bowel disease and cystic fibrosis. By harnessing the power of bacteriophages, BiomX aims to deliver precision therapies that selectively target harmful bacteria while preserving the beneficial microbiome. Committed to rigorous research and development, BiomX collaborates with academic and industry partners to advance its mission of improving patient outcomes through microbiome-based therapeutics.
